Klinge Pharma
- Company typePrivate
- Founded1933
- HeadquartersHolzkirchen, Germany
- Headcount51–100
- GTM typeB2B
- OfferingHardware or Manufacturing
Klinge Pharma firmographics
Firmographics- Name
- Klinge Pharma
- Legal name
- Klinge Pharma GmbH
- Website
- https://klinge-pharma.com
- Company type
- Private
- Founded year
- 1933
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Ownership category
- akta.pro rank
Klinge Pharma industry classification
Industry- Product category
- Pharmaceuticals
- NAICS
- Pharmaceutical Preparation Manufacturing (325412), Drugs and Druggists' Sundries Merchant Wholesalers (424210)
- SIC
- Pharmaceutical Preparations (2834), Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)
- akta.pro primary industry
- OTC & Consumer Health Distributors (HLAIAJAC)
- akta.pro secondary industries
- OTC Medicines & Consumer Health Products Distribution (CRAOAHAB), Pharmacy Front-End & Sundries Distribution (Health & Wellness, Personal Care, Convenience) (CRAOAHAG)
Keywords
Where Klinge Pharma is headquartered
LocationHeadquarters
- HQ city
- Holzkirchen
- HQ country
- Germany
- HQ region
- Europe
Offices1 record
Markets served
Klinge Pharma business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Supply Chain, Marketing or Sales, Technology or R&D, Operations
Revenue model
- Pharmaceutical Product Sales: Klinge Pharma manufactures and sells prescription and OTC pharmaceutical products through pharmacy distribution channels in Germany and potentially other markets. Revenue is generated through product sales across their four therapeutic areas: gastrointestinal health, dermatology, venous health, and urinary tract health.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Unit Pricing | Pay-as-you-go | Vomex A multiple dosage forms and strengths |
| Unit Pricing | Pay-as-you-go | Venostasin venous health products |
| Unit Pricing | Pay-as-you-go | Arctuvan urinary tract infection treatment |
| Unit Pricing | Pay-as-you-go | UTIPRO bladder infection prevention |
| Unit Pricing | Pay-as-you-go | Physiogel dermatology products |
Go-to-market motion2 records
Distribution channels3 records
Marketing channels6 records
Klinge Pharma product offering
Product offeringCore offering
Klinge Pharma manufactures and distributes a portfolio of over-the-counter (OTC) and prescription pharmaceutical products through pharmacies in Germany, spanning four therapeutic areas: gastrointestinal health (e.g., Vomex A, Carvomin, Kohle Compretten, Elytro), dermatology (Physiogel, Ketoconazol Klinge), venous health (Venostasin), and urinary tract health (UTIPRO, Arctuvan). The company sells approximately 32 products to pharmacies, which dispense them to end consumers and patients based on prescriptions or self-medication needs.
Product overview
Klinge Pharma is a pharmaceutical company offering a diversified portfolio of over 32 products across four main indication areas: gastrointestinal health (Vomex A, Carvomin, Lingumelt, Kohle Compretten, Ultracarbon, Elytro, DiaVerde), dermatology (Physiogel, Ketoconazol Klinge, Adapaben, Betasacyl, Sumilor), vein health (Venostasin), and urinary tract health (UTIPRO akut & protect, Arctuvan). Additional products include Binko and Binko Memo for memory and circulation, BronchoVerde for respiratory relief, and Vertigo Vomex SR for vertigo. The company also offers training and continuing education services for healthcare professionals through their Fachbereich portal. Products are available both over-the-counter in pharmacies and through prescription.
Differentiator
Problem solved
Functional benefit
Brands
- Vomex A®: Die Nr. 1 bei Übelkeit & Erbrechen. Rezeptfreies Medikament in verschiedenen Darreichungsformen (Dragees, Retardkapseln, Suppositorien, Sirup, Lösung).
- Physiogel®
- Ketoconazol Klinge®
- Venostasin®
- UTIPRO® akut & protect
- Arctuvan®
- Lingumelt® akut
- Kohle Compretten®
- Carvomin® Verdauungstropfen
- Elytro®
- Ultracarbon®
- Binko® / Binko Memo®
- BronchoVerde®
- Vertigo Vomex SR®
- DiaVerde®
Products and services
- Vomex A The number 1 brand in Germany for nausea and vomiting relief (IQVIA Absatz MAT 06/2023), available in multiple dosage forms including dragees, retard capsules, suppositories, syrup, and solution. Sold OTC through pharmacies.
- Physiogel Dermatology product line for dry and sensitive skin, including Daily Moisture Therapy, Calming Relief A.I., Calming Relief, and Scalp Care series. Uses BioMimetic Technology with microbiome-neutral formulations free from fragrance, dyes, silicones, preservatives, and emulsifiers.
- Ketoconazol Klinge Medical shampoo for the prevention and treatment of scalp scaling and seborrheic dermatitis.
- Venostasin
Quantifiable outcome
- Vomex A is the #1 brand for nausea and vomiting in Germany (IQVIA Absatz MAT 06/2023)
- +2 more outcomes
Companies that use Klinge Pharma
Customer profileNamed customers3 records
Segments3 records
Ideal customer profiles2 records
Klinge Pharma technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature3 records
Klinge Pharma partnerships and signals
Strategic signalPartnerships
Three partnerships are on record, tiered core and minor.
- Teva (Klinge-Teva)corePartnership with Teva for major European markets and Israel for Eylea biosimilar (Ahzantive). Settlement with Regeneron secured on October 2, 2025 resolving US patent litigation, permitting US launch in Q4 2026.
- MarpinionminorCooperation partner for continuing education offerings. Marpinion provides training programs and evening seminars for pharmacists as part of Klinge Pharma's professional education offerings.
- DocCheckcoreDocCheck provides authentication services for the Fachbereich professional portal. Healthcare professionals must use DocCheck credentials to access prescription product information and professional resources.
Scale indicators6 records
Recent moves8 records
Expansion highlights6 records
Klinge Pharma competitors and assessment
Company assessmentDirect peers
- Stada Arzneimittel AG: German-headquartered specialty pharma with a large OTC and generics portfolio distributed through German pharmacies. Closest direct comparable on geography, channel (pharmacy), and product mix (OTC + prescription, branded generics).
- Biologische Heilmittel Heel GmbH: German-based pharma specializing in natural/combination homeopathic and herbal OTC medicines distributed through pharmacies and practitioners. Comparable therapeutic categories (GI, dermatology) and German pharmacy-channel focus.
- Dermapharm Holding SE: German mid-sized pharma focused on branded dermatology, allergy, and pain products sold through pharmacies. Highly comparable on size, growth profile, German pharmacy distribution, and buy-and-build strategy.
- Hermes Arzneimittel GmbH: Privately owned German OTC pharma (Biolectra, doc, Aspecton) distributed through German pharmacies. Highly comparable on size, OTC focus, and family-owned mid-cap profile.
- Engelhard Arzneimittel GmbH & Co. KG: Mid-sized German pharma with OTC brands (e.g., isla-Moos, Sinupret) sold through pharmacies. Comparable on family/mid-cap ownership, pharmacy channel, and OTC therapeutic-area focus.
- Klosterfrau Vertriebsgesellschaft mbH: German heritage pharma company with a portfolio of OTC natural medicine brands (Klosterfrau Melissengeist, Taxofit) sold through pharmacies. Comparable on German focus, OTC brand heritage, and pharmacy channel.
Broad incumbents
- Bayer Consumer Health: Global OTC and consumer-health division of Bayer with major pharmacy brands in Germany. Competes directly on the same German pharmacy shelves but with vastly greater scale, marketing spend, and global pipeline.
- Sanofi Consumer Health (Opella): Global consumer-health business (carved out as Opella) including German OTC brands. Overlaps with Klinge across GI, dermatology, and women's health OTC categories via German pharmacy distribution.
- Merz Pharma GmbH & Co. KGaA: Privately held German pharma across prescription, aesthetics, and consumer health (e.g., tetesept, Merz Spezial). Overlaps with Klinge in OTC consumer health and German pharmacy distribution but is broader in portfolio.
- ratiopharm (Teva): Germany's leading generic and OTC brand owned by Teva, sold through pharmacies. Direct competitor across many of Klinge's OTC categories and connected to Teva via the Klinge-Teva biosimilar partnership.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
Klinge Pharma social profiles
Digital presenceKlinge Pharma financial estimates
Financial estimateRevenue estimate
Valuation estimate
Klinge Pharma leadership team
Management profileNumber of profiles
Profiles3 records
Klinge Pharma subsidiaries and ownership
Company hierarchySubsidiaries1 record
Klinge Pharma funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Klinge Pharma M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Klinge Pharma
What does Klinge Pharma do?
Klinge Pharma manufactures and distributes a portfolio of over-the-counter (OTC) and prescription pharmaceutical products through pharmacies in Germany, spanning four therapeutic areas: gastrointestinal health (e.g., Vomex A, Carvomin, Kohle Compretten, Elytro), dermatology (Physiogel, Ketoconazol Klinge), venous health (Venostasin), and urinary tract health (UTIPRO, Arctuvan). The company sells approximately 32 products to pharmacies, which dispense them to end consumers and patients based on prescriptions or self-medication needs.
Is Klinge Pharma a public or private company?
Klinge Pharma is a private company. It is classified as family owned and is currently operating.
When was Klinge Pharma founded?
Klinge Pharma was founded in 1933. It employs 51 to 100 people.
Where is Klinge Pharma based?
Klinge Pharma is headquartered in Holzkirchen, Germany, in the Europe region.
How does Klinge Pharma make money?
One revenue line is on record: pharmaceutical Product Sales.
Who are Klinge Pharma's main competitors?
Direct peers on record are Stada Arzneimittel AG, Biologische Heilmittel Heel GmbH, Dermapharm Holding SE, Hermes Arzneimittel GmbH, Engelhard Arzneimittel GmbH & Co. KG and Klosterfrau Vertriebsgesellschaft mbH. Broad incumbents are Bayer Consumer Health, Sanofi Consumer Health (Opella), Merz Pharma GmbH & Co. KGaA and ratiopharm (Teva).
Does Klinge Pharma have an API?
No public API is recorded for Klinge Pharma.
What industry is Klinge Pharma in?
Klinge Pharma's product category is Pharmaceuticals. Its primary akta.pro industry code is HLAIAJAC, OTC & Consumer Health Distributors, with a secondary code of CRAOAHAB, OTC Medicines & Consumer Health Products Distribution. Its NAICS code is 325412 and its SIC code is 2834.